The efectiveness and acceptability of evidence synthesis summary formats for clinical guideline development groups: a mixed-methods systematic review
Introduction: Clinical guideline development often involves a rigorous synthesis of evidence involving multidisciplinary stakeholders with diferent priorities and knowledge of evidence synthesis; this makes communicating fndings complex. Summary formats are typically used to communicate the results of evidence syntheses; however, there is little consensus on which formats are most efective and acceptable for diferent stakeholders.
Methods: This mixed-methods systematic review (MMSR) aimed to evaluate the efectiveness and acceptability (e.g. preferences and attitudes and preferences towards) of evidence synthesis summary formats for GDG members. We followed the PRISMA 2020 guideline and Joanna Briggs Institute Manual for Evidence Synthesis for MMSRs. We searched six databases (inception to April 20, 2021) for randomised controlled trials (RCTs), RCTs with a qualitative component, and qualitative studies. Screening, data extraction, and quality appraisal were performed in duplicate. Qualitative fndings were synthesised using meta-aggregation, and quantitative fndings are described narratively.
Results: We identifed 17,240 citations and screened 54 full-text articles, resulting in 22 eligible articles (20 unique studies): 4 articles reported the results of 5 RCTs, one of which also had a qualitative component. The other 18 articles discussed the results of 16 qualitative studies. Therefore, we had 5 trials and 17 qualitative studies to extract data from. Studies were geographically heterogeneous and included a variety of stakeholders and summary formats. All 5 RCTs assessed knowledge or understanding with 3 reporting improvement with newer formats. The qualitative analysis identifed 6 categories of recommendations: ‘presenting information’, ‘tailoring information’ for end users, ‘trust in producers and summary’, ‘knowledge required’ to understand fndings, ‘quality of evidence’, and properly ‘contextualising information’. Across these categories, the synthesis resulted in 126 recommendations for practice. Nine recommendations were supported by both quantitative and qualitative evidence and 116 by only qualitative. A majority focused on how to present information (n = 64) and tailor content for diferent end users (n = 24).
Conclusions: This MMSR provides guidance on how to improve evidence summary structure and layout. This can be used by synthesis producers to better communicate to GDGs. Study fndings will inform the co-creation of evidence summary format prototypes based on GDG member’s needs.
Trial registration The protocol for this project was previously published, and the project was preregistered on Open Science Framework (Clyne and Sharp, Evidence synthesis and translation of fndings for national clinical guideline development: addressing the needs and preferences of guideline development groups, 2021; Sharp and Clyne, Evidence synthesis summary formats for decision-makers and Clinical Guideline Development Groups: A mixed-methods systematic review protocol, 2021).
Health Research Board (HRB) Emerging Investigator Award (EIA-2019-09)
Associated research data filesThe study was previously preregistered on the Open Science Framework, and the protocol was published in HRB Open Research. The datasets generated and/or analysed during the current study are available on Open Science Framework (OSF). Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
CommentsThe original article is available at https://implementationscience.biomedcentral.com/
Published CitationSharp MK. The efectiveness and acceptability of evidence synthesis summary formats for clinical guideline development groups: a mixed-methods systematic review. Implementation Sci. 2022;17:74
Publication Date27 October 2022
- General Practice
- Undergraduate Research
- Published Version (Version of Record)